In-Vitro and In-Vivo Anticancer Activity of Hydroethanolic Root Extracts of Calotropis gigantea and Bauhinia variegata Against Ehrlich Ascites Carcinoma
International Journal of Drug Delivery Technology · 25.04.2026 · 16 (19s)
DOI: 10.25258/ijddt.16.19s.42 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 25.04.2026. Verfasst von Arshad Ali und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Background and Objective: Cancer continues to impose an enormous global burden, with inadequacies in conventional therapy necessitating the exploration of plant-derived alternatives. Calotropis gigantea and Bauhinia variegata are traditionally employed for tumor-related conditions in Ayurvedic medicine. This study investigated the in-vitro cytotoxic and in-vivo anticancer potential of their hydroethanolic root extracts against Ehrlich Ascites Carcinoma (EAC). Materials and Methods: In-vitro cytotoxicity was assessed using the MTT assay on EAC cells. In-vivo anticancer activity was evaluated in EAC-bearing Swiss albino mice (n = 6 per group) at doses of 100, 200, and 400 mg/kg (p.o., 14 days). Parameters included mean survival time (MST), percentage increase in life span (%ILS), packed cell volume (PCV), tumor cell count, hematological indices, serum biochemical markers, and invivo antioxidant status (SOD, CAT, GST, MDA). Cyclophosphamide (25 mg/kg, i.p.) served as the reference standard. Histopathological examination of liver and tumor tissues was performed. Acute oral toxicity was assessed per OECD Guideline 423.
Results
CG showed greater in-vitro cytotoxicity (IC₅₀ = 94.6 μg/mL) than BV (IC₅₀ = 128.3 μg/mL). In-vivo, CG at 400 mg/kg increased MST to 32.1 ± 1.2 days (%ILS = 74.4%) and BV to 30.2 ± 1.2 days (%ILS = 64.1%), both significantly superior to EAC control (MST = 18.4 days; p < 0.01). Both extracts significantly reduced PCV, tumor cell count, and restored hematological and biochemical parameters (p < 0.01). BV demonstrated superior restoration of antioxidant enzymes (SOD, CAT, GST) and greater reduction of MDA. Histopathology confirmed near-normal liver architecture (CG) and moderate hepatoprotection (BV). No mortality or toxicity was observed up to 2000 mg/kg.
Conclusion
C. gigantea exhibited stronger anticancer efficacy through cytotoxic and pro-apoptotic mechanisms, while B. variegata provided superior antioxidant enzyme restoration. Both extracts present complementary, multi-targeted therapeutic profiles warranting further molecular investigation.
Zitieren
APA
Ali, A., & Sisodia, S. S. (2026). In-Vitro and In-Vivo Anticancer Activity of Hydroethanolic Root Extracts of Calotropis gigantea and Bauhinia variegata Against Ehrlich Ascites Carcinoma. International Journal of Drug Delivery Technology, 16(19s). https://doi.org/10.25258/ijddt.16.19s.42
Vancouver
Ali A, Sisodia SS. In-Vitro and In-Vivo Anticancer Activity of Hydroethanolic Root Extracts of Calotropis gigantea and Bauhinia variegata Against Ehrlich Ascites Carcinoma. International Journal of Drug Delivery Technology. 2026;16(19s). doi:10.25258/ijddt.16.19s.42
BibTeX
@article{Ali2026,
author = {Ali, Arshad and Sisodia, S. S.},
title = {In-Vitro and In-Vivo Anticancer Activity of Hydroethanolic Root Extracts of Calotropis gigantea and Bauhinia variegata Against Ehrlich Ascites Carcinoma},
journal = {International Journal of Drug Delivery Technology},
year = {2026},
volume = {16},
number = {19s},
doi = {10.25258/ijddt.16.19s.42}
}
EUVIMED